FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2062145860> ?p ?o ?g. }

• W2062145860 endingPage "427" @default.
• W2062145860 startingPage "423" @default.
• W2062145860 abstract "The high frequency of relapse after induction chemotherapy in advanced ovarian carcinoma patients calls for new therapeutic modalities. Retargeted T cell-mediated lysis can be achieved using the bispecific antibody (BsmAb) OCTR, directed to CD3 on T cells and to the folate receptor on ovarian carcinoma cells. Twenty-eight patients with limited intraperitoneal disease after first-line therapy entered a phase II study. They received two i.p. 5 day cycles of activated PBMC retargeted with OCTR. Despite unfavorable tumor characteristics, 7 of 26 patients (27%) showed complete or partial intraperitoneal responses with strict surgicopathologic evaluation. In most cases, the disease relapsed outside the peritoneal cavity, and in 1 case complete intraperitoneal response was accompanied by progression in retroperitoneal lymph nodes. The morbidity was mild to moderate and transient. Combination of i.v. and i.p. administration of OCTR-retargeted lymphocytes will possibly lead to extraperitoneal cure. Ongoing clinical studies indicate that the i.v. infusion of up to 8 X 108 OCTR-retargeted T lymphocytes does not induce a higher toxicity than the i.p. treatment. To avoid PBMC preactivation, new approaches for delivering accessory signals are under investigation. Preliminary results indicate that nonactivated PBMC retargeted by OCTR in the presence of an anti-CD28 monoclonal antibody (mAb) are able to significantly inhibit tumor growth." @default.
• W2062145860 created "2016-06-24" @default.
• W2062145860 creator A5007087777 @default.
• W2062145860 creator A5010553869 @default.
• W2062145860 creator A5018594390 @default.
• W2062145860 creator A5037526893 @default.
• W2062145860 creator A5041717556 @default.
• W2062145860 creator A5046199103 @default.
• W2062145860 creator A5071853164 @default.
• W2062145860 creator A5091716433 @default.
• W2062145860 date "1995-10-01" @default.
• W2062145860 modified "2023-10-15" @default.
• W2062145860 title "Bispecific Antibody Targeted T Cell Therapy of Ovarian Cancer: Clinical Results and Future Directions" @default.
• W2062145860 cites W1734084813 @default.
• W2062145860 cites W1880772556 @default.
• W2062145860 cites W1903927332 @default.
• W2062145860 cites W1994535661 @default.
• W2062145860 cites W2002640040 @default.
• W2062145860 cites W2006492631 @default.
• W2062145860 cites W2018235031 @default.
• W2062145860 cites W2020426610 @default.
• W2062145860 cites W2024354916 @default.
• W2062145860 cites W2060726255 @default.
• W2062145860 cites W2064525881 @default.
• W2062145860 cites W2065272367 @default.
• W2062145860 cites W2072281294 @default.
• W2062145860 cites W2086857441 @default.
• W2062145860 cites W2110544075 @default.
• W2062145860 cites W2117995467 @default.
• W2062145860 cites W2155250860 @default.
• W2062145860 cites W2263945355 @default.
• W2062145860 cites W2292318630 @default.
• W2062145860 doi "https://doi.org/10.1089/scd.1.1995.4.423" @default.
• W2062145860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8581379" @default.
• W2062145860 hasPublicationYear "1995" @default.
• W2062145860 type Work @default.
• W2062145860 sameAs 2062145860 @default.
• W2062145860 citedByCount "44" @default.
• W2062145860 countsByYear W20621458602012 @default.
• W2062145860 countsByYear W20621458602013 @default.
• W2062145860 countsByYear W20621458602014 @default.
• W2062145860 countsByYear W20621458602016 @default.
• W2062145860 countsByYear W20621458602017 @default.
• W2062145860 countsByYear W20621458602018 @default.
• W2062145860 crossrefType "journal-article" @default.
• W2062145860 hasAuthorship W2062145860A5007087777 @default.
• W2062145860 hasAuthorship W2062145860A5010553869 @default.
• W2062145860 hasAuthorship W2062145860A5018594390 @default.
• W2062145860 hasAuthorship W2062145860A5037526893 @default.
• W2062145860 hasAuthorship W2062145860A5041717556 @default.
• W2062145860 hasAuthorship W2062145860A5046199103 @default.
• W2062145860 hasAuthorship W2062145860A5071853164 @default.
• W2062145860 hasAuthorship W2062145860A5091716433 @default.
• W2062145860 hasConcept C121608353 @default.
• W2062145860 hasConcept C126322002 @default.
• W2062145860 hasConcept C137061746 @default.
• W2062145860 hasConcept C143998085 @default.
• W2062145860 hasConcept C159654299 @default.
• W2062145860 hasConcept C202751555 @default.
• W2062145860 hasConcept C203014093 @default.
• W2062145860 hasConcept C2776694085 @default.
• W2062145860 hasConcept C2780427987 @default.
• W2062145860 hasConcept C3019054536 @default.
• W2062145860 hasConcept C502942594 @default.
• W2062145860 hasConcept C542903549 @default.
• W2062145860 hasConcept C55493867 @default.
• W2062145860 hasConcept C71924100 @default.
• W2062145860 hasConcept C86803240 @default.
• W2062145860 hasConcept C90924648 @default.
• W2062145860 hasConceptScore W2062145860C121608353 @default.
• W2062145860 hasConceptScore W2062145860C126322002 @default.
• W2062145860 hasConceptScore W2062145860C137061746 @default.
• W2062145860 hasConceptScore W2062145860C143998085 @default.
• W2062145860 hasConceptScore W2062145860C159654299 @default.
• W2062145860 hasConceptScore W2062145860C202751555 @default.
• W2062145860 hasConceptScore W2062145860C203014093 @default.
• W2062145860 hasConceptScore W2062145860C2776694085 @default.
• W2062145860 hasConceptScore W2062145860C2780427987 @default.
• W2062145860 hasConceptScore W2062145860C3019054536 @default.
• W2062145860 hasConceptScore W2062145860C502942594 @default.
• W2062145860 hasConceptScore W2062145860C542903549 @default.
• W2062145860 hasConceptScore W2062145860C55493867 @default.
• W2062145860 hasConceptScore W2062145860C71924100 @default.
• W2062145860 hasConceptScore W2062145860C86803240 @default.
• W2062145860 hasConceptScore W2062145860C90924648 @default.
• W2062145860 hasIssue "5" @default.
• W2062145860 hasLocation W20621458601 @default.
• W2062145860 hasLocation W20621458602 @default.
• W2062145860 hasOpenAccess W2062145860 @default.
• W2062145860 hasPrimaryLocation W20621458601 @default.
• W2062145860 hasRelatedWork W178507842 @default.
• W2062145860 hasRelatedWork W1967715255 @default.
• W2062145860 hasRelatedWork W1986424797 @default.
• W2062145860 hasRelatedWork W2013104097 @default.
• W2062145860 hasRelatedWork W2039279058 @default.
• W2062145860 hasRelatedWork W2052586637 @default.
• W2062145860 hasRelatedWork W2400608262 @default.
• W2062145860 hasRelatedWork W2509512733 @default.

• next